Back to search

Article

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer

2022-03-08

Abstract excerpt

Non-small-cell lung cancer (NSCLC) is one of the most common malignancies, and specific molecular targets are still lacking. Angiogenesis plays a central regulatory role in the growth and metastasis of malignant tumor. Angiogenic factors (AFs) are involved. Although there are many studies comparing AFs and cancer, a prognostic risk model for AFs and cancer in humans has not been reported in the literature. This st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ad0a8ac-8d80-5d9c-a651-68d2ecc548f5
DOI
10.21203/rs.3.rs-1406018/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung CancerDOI 10.21203/rs.3.rs-1406018/v1
Select a neighboring publication to make it the new centre.